But EGFR overexpression was associated with tumor stage, with the percentage of patients with EGFR overexpression was higher in TNM stage IV than in stages I/II/III CRCs (33% versus 12% respectively, P = 0.023) (data not shown). Here, EGFR is linked to neoplasm.